Meet our team

Marius is a PostDoc at the Department of Biomedical Imaging and Image-guided Therapy at the Medical University of Vienna. During his PhD he worked extensively on the development of antagonists for the muscarinic acetylcholine receptor. His research interest cover radiotracer development, carbon-11 and fluoride-18 radiochemistry and radiopharmaceutical evaluation of PET tracer.

Karsten is a PhD student in his last year and his research interests are in PET radiotracer development, medicinal chemistry and preclinical drug evaluation. He is based on the Department of Biomedical Imaging and Image-guided therapy of the Medical University of Vienna. In cooperation with MUW and CBmed Graz, we develope small molecule inhibitors towards oncological targets. Karsten performs his organic synthesis in our labs.

Marlon started his PhD in March 2020 in the neurochem group. He has extensive knowledge in computational methods for drug design as well on organic medicinal chemistry. He is involved in the muscaPET Project and develops small molecular inhibitors for the muscarinic acetylcholine receptor based on a pirenzepine-associated core structure.

Irem started in our group in July 2022 and completes our interdisciplinary and international team. Irem works on our patented dynamic 3D cell culture and has a strong expertise in biomedical engineering, cell culture and advanced biochemical technologies. This project is in strong cooperation with the FH Technikum Wien, Medical University of Vienna and DOCMedikus GmbH.

Lukas Kogler

Lukas studied chemistry and biochemistry at the university of vienna and synthesized precursors and reference compounds for the establishment of a new carbon-11 labelling strategy during his master´s thesis. For his Phd, he is now working in the "Microone" project, which tries to determine potential negative health impacts of microplastics. For that labelled microparticles need to be synthesized, which can be used to determine biodistribution and accumulation in vivo.

Verena Maisetschläger

After her “Aspirantenjahr”, Verena returned to the neurochem group for her PhD thesis in January 2023. Like Irem, she works on our patented dynamic 3D cell culture project. She brings along a know-how in analytics, especially working with HPLC. Her main part in the project is working with radiotracers at our cooperation partner, the Medical University of Vienna.

Viktoria Mair

Viktorias research focuses on the investigations on ligand-receptor interactions of antagonists towards the muscarinic acetylcholine receptors.

Fjolla Sejdiu

Fjolla works on the biological evaluation on advanced mAChR targeting rotamers compounds and fluorescence techniques.

Ines Aykara

Ines deals with the new CTIS system for clinical trials and enhaces our knowledge on a facilitated transition of drugs from bench to bedside.

Florian Schwingenschlögl

Florian establishes two different approaches for the radiosynthesis of [18F]FAC in cooperation with Prof. Cecile Philippe at the Medical University of Vienna.

Stefan Bittner

Stefan works on the development of fluorescently and Au-nanoparticle labeled proteins towards multimodal imaging in vitro and in vivo.

Elma Joldic

Elma started to create and design innovative retainer and incubators for our spheriograph system to study the effects of radiation exposure to cells and tissues.

Carolin Bapp

Carolin works on the project uONE in cooperation with CBmed GmbH in Graz, Medical University of Vienna and numerous international partners to clarify the effects of micro- and nanoplastics on human healt.

Romana Langsenlehner

Romana will synthesize, characterize and analyse precursors molecules for the production of radiopharmaceuticals.

Alaa Mohammed

Alaa evaluates the toxicity of micro- and nanoplastic particles in vitro.

Elisabeth Schögl

Motivated by the current increasing proof of the health risk of micro- and nanopastic, Elisabeth investigates the impact of these particles in cancer cells.

Sarah Stellenberger

Sarah is our analytical expert and developes assays for our fully automated Sirius T3 system, to investigate pKa and logP of CNS active neurochemicals.

Alexandra Andrisinova

Alexandras research focuses on the regulatory challenges and opportunities of theranostic radiopharmaceuticals.